1. Home
  2. FTFT vs RNAZ Comparison

FTFT vs RNAZ Comparison

Compare FTFT & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

HOLD

Current Price

$1.60

Market Cap

6.9M

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

HOLD

Current Price

$8.64

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTFT
RNAZ
Founded
N/A
2016
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
5.6M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
FTFT
RNAZ
Price
$1.60
$8.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
146.4K
28.0K
Earning Date
05-19-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,829,805.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
77.46
N/A
52 Week Low
$0.45
$3.82
52 Week High
$3.88
$20.99

Technical Indicators

Market Signals
Indicator
FTFT
RNAZ
Relative Strength Index (RSI) 70.25 60.76
Support Level $1.29 $8.38
Resistance Level $1.70 $9.68
Average True Range (ATR) 0.11 1.21
MACD 0.12 0.30
Stochastic Oscillator 73.57 66.46

Price Performance

Historical Comparison
FTFT
RNAZ

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the production and sale of fruit juice concentrates (including fruit purees and fruit juices), fruit beverages (including fruit juice beverages and fruit cider beverages) in the PRC. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The Company classified its business segments into Trading Commission and Consulting services, Fast-Moving Consumer Goods (FMCG), and Supply Chain Financing and Trading.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Share on Social Networks: